← Open Payments lookup

MOISES FAJARDO: Open Payments

NPI 1740683069 · CLAWSON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,153 in 40 payments from 22 companies in 2025. Trend: 2023 $1,817 · 2024 $4,048 · 2025 $3,153

Food & beverage: $2,454Long term medical supply or device loan: $699
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation9$732
AstraZeneca Pharmaceuticals LP4$288
Amgen Inc.2$195
Incyte Corporation2$179
Janssen Biotech, Inc.3$146
Averitas Pharma Inc.1$145
JAZZ PHARMACEUTICALS INC.2$136
Axsome Therapeutics, Inc.2$135
Alexion Pharmaceuticals, Inc.1$126
Agios Pharmaceuticals, Inc.1$125

Products named: KISQALI, IMDELLTRA (AMG757), QUTENZA, Auvelity, PYRUKYND, Wegovy, EPIDIOLEX, REXULTI.

Industry payments across MI — which companies pay providers there.